Author: Mercaptor

news

Enabled Therapeutics Announces Board Appointment of Jivan Achreja as It Introduces a New Era in Precision Neurology

Post author By Mercaptor
Post date April 30, 2025

<img width="625" height="526" src="https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="Jivan Achreja" decoding="async" srcset="https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2.png 625w, https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2-300x252.png 300w" sizes="(max-width: 625px) 100vw, 625px" />

Enabled Therapeutics strengthens leadership team as it redefines neurology with on-site drug synthesis and precision brain therapeutics.

board

Jivan Achreja, Board of Directors

Post author By Mercaptor
Post date April 29, 2025

<img width="625" height="526" src="https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2.png" class="attachment-post-thumbnail size-post-thumbnail wp-post-image" alt="Jivan Achreja" decoding="async" srcset="https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2.png 625w, https://enabledtherapeutics.com/wp-content/uploads/2025/04/UTF-8JSA-Headshot-2-300x252.png 300w" sizes="(max-width: 625px) 100vw, 625px" />

Jivan Achreja is Co-Founder and CTO of Recombo.AI and ETHOS Scientific, and a veteran technology leader in healthcare and life sciences.

news

Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s

Post author By Mercaptor
Post date March 24, 2025

Enabled Therapeutics Gains FDA Alignment for CPT-021: A First-of-Its-Kind Targeted Therapy for Alzheimer’s